| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |